(SGO) Compagnie de Saint-Gobain - Overview
Stock: Building Materials, Insulation, Glass, Mortars, Ceilings
| Risk 5d forecast | |
|---|---|
| Volatility | 39.4% |
| Relative Tail Risk | -4.98% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.85 |
| Alpha | -38.48 |
| Character TTM | |
|---|---|
| Beta | 0.585 |
| Beta Downside | 0.084 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.29% |
| CAGR/Max DD | 0.52 |
Description: SGO Compagnie de Saint-Gobain March 03, 2026
Compagnie de Saint-Gobain S.A. is a diversified global manufacturer and distributor of materials for the construction and industrial markets. Headquartered in France and operating through five geographic and solution-based segments, the company produces a wide array of building components, including plaster systems, insulation, architectural glazing, and construction chemicals under brands such as CertainTeed, Isover, and Weber. The firm also manufactures high-performance industrial solutions, supplying ceramics, abrasives, and technical textiles to the automotive and renewable energy sectors.
The company operates within the cyclical building products industry, where financial performance is often linked to housing starts, renovation trends, and infrastructure spending. Saint-Gobain utilizes a vertically integrated business model that combines manufacturing with a vast distribution network for plumbing, timber, and heavy building materials, securing a presence across the entire supply chain. For deeper analysis of Saint-Gobains valuation metrics, investors can review the data available on ValueRay. In addition to core construction supplies, the company provides specialized exterior products like asphalt roofing and solar cladding solutions.
Headlines to watch out for
- Construction market demand impacts material sales
- Energy efficiency regulations drive insulation product growth
- Raw material cost fluctuations compress profit margins
- Global economic slowdown reduces industrial product orders
- Currency exchange rates affect international revenue translation
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 4.91b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 1.57 > 1.0 |
| NWC/Revenue: 4.85% < 20% (prev 11.79%; Δ -6.94% < -1%) |
| CFO/TA 0.18 > 3% & CFO 11.21b > Net Income 4.91b |
| Net Debt (13.00b) to EBITDA (11.92b): 1.09 < 3 |
| Current Ratio: 1.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (493.0m) vs 12m ago -2.67% < -2% |
| Gross Margin: 27.30% > 18% (prev 0.27%; Δ 2703 % > 0.5%) |
| Asset Turnover: 157.5% > 50% (prev 83.67%; Δ 73.87% > 0%) |
| Interest Coverage Ratio: 5.58 > 6 (EBITDA TTM 11.92b / Interest Expense TTM 1.48b) |
Altman Z'' 3.34
| A: 0.07 (Total Current Assets 21.36b - Total Current Liabilities 16.84b) / Total Assets 60.84b |
| B: 0.37 (Retained Earnings 22.22b / Total Assets 60.84b) |
| C: 0.14 (EBIT TTM 8.26b / Avg Total Assets 59.07b) |
| D: 0.69 (Book Value of Equity 24.54b / Total Liabilities 35.73b) |
| Altman-Z'' Score: 3.34 = A |
Beneish M -2.84
| DSRI: 0.52 (Receivables 6.60b/6.58b, Revenue 93.05b/47.94b) |
| GMI: 0.97 (GM 27.30% / 26.57%) |
| AQI: 1.06 (AQ_t 0.36 / AQ_t-1 0.34) |
| SGI: 1.94 (Revenue 93.05b / 47.94b) |
| TATA: -0.10 (NI 4.91b - CFO 11.21b) / TA 60.84b) |
| Beneish M-Score: -2.84 (Cap -4..+1) = A |
What is the price of SGO shares?
Over the past week, the price has changed by -11.50%, over one month by -16.94%, over three months by -13.10% and over the past year by -25.19%.
Is SGO a buy, sell or hold?
What are the forecasts/targets for the SGO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 102.7 | 40.2% |
| Analysts Target Price | - | - |
SGO Fundamental Data Overview March 09, 2026
P/E Trailing = 13.1779
P/E Forward = 11.534
P/S = 0.79
P/B = 1.5883
P/EG = 1.4343
Revenue TTM = 93.05b EUR
EBIT TTM = 8.26b EUR
EBITDA TTM = 11.92b EUR
Long Term Debt = 13.09b EUR (from longTermDebt, two quarters ago)
Short Term Debt = 3.35b EUR (from shortTermDebt, last quarter)
Debt = 20.58b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 13.00b EUR (from netDebt column, last quarter)
Enterprise Value = 49.57b EUR (36.72b + Debt 20.58b - CCE 7.73b)
Interest Coverage Ratio = 5.58 (Ebit TTM 8.26b / Interest Expense TTM 1.48b)
EV/FCF = 7.34x (Enterprise Value 49.57b / FCF TTM 6.76b)
FCF Yield = 13.63% (FCF TTM 6.76b / Enterprise Value 49.57b)
FCF Margin = 7.26% (FCF TTM 6.76b / Revenue TTM 93.05b)
Net Margin = 5.28% (Net Income TTM 4.91b / Revenue TTM 93.05b)
Gross Margin = 27.30% ((Revenue TTM 93.05b - Cost of Revenue TTM 67.65b) / Revenue TTM)
Gross Margin QoQ = 26.74% (prev 28.59%)
Tobins Q-Ratio = 0.81 (Enterprise Value 49.57b / Total Assets 60.84b)
Interest Expense / Debt = 1.81% (Interest Expense 372.0m / Debt 20.58b)
Taxrate = 24.05% (677.0m / 2.82b)
NOPAT = 6.27b (EBIT 8.26b * (1 - 24.05%))
Current Ratio = 1.27 (Total Current Assets 21.36b / Total Current Liabilities 16.84b)
Debt / Equity = 0.84 (Debt 20.58b / totalStockholderEquity, last quarter 24.54b)
Debt / EBITDA = 1.09 (Net Debt 13.00b / EBITDA 11.92b)
Debt / FCF = 1.92 (Net Debt 13.00b / FCF TTM 6.76b)
Total Stockholder Equity = 24.30b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.32% (Net Income 4.91b / Total Assets 60.84b)
RoE = 20.22% (Net Income TTM 4.91b / Total Stockholder Equity 24.30b)
RoCE = 22.08% (EBIT 8.26b / Capital Employed (Equity 24.30b + L.T.Debt 13.09b))
RoIC = 16.10% (NOPAT 6.27b / Invested Capital 38.93b)
WACC = 5.66% (E(36.72b)/V(57.30b) * Re(8.07%) + D(20.58b)/V(57.30b) * Rd(1.81%) * (1-Tc(0.24)))
Discount Rate = 8.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.35%
[DCF] Terminal Value 88.35% ; FCFF base≈6.24b ; Y1≈7.62b ; Y5≈12.68b
[DCF] Fair Price = 723.5 (EV 369.69b - Net Debt 13.00b = Equity 356.69b / Shares 493.0m; r=5.90% [WACC]; 5y FCF grow 23.66% → 2.90% )
EPS Correlation: -8.83 | EPS CAGR: -55.60% | SUE: 0.02 | # QB: 0
Revenue Correlation: -8.45 | Revenue CAGR: 22.03% | SUE: -0.00 | # QB: 0
EPS current Year (2026-12-31): EPS=6.63 | Chg7d=-0.103 | Chg30d=-0.138 | Revisions Net=-1 | Growth EPS=-1.0% | Growth Revenue=+1.6%
EPS next Year (2027-12-31): EPS=7.37 | Chg7d=-0.098 | Chg30d=-0.116 | Revisions Net=-4 | Growth EPS=+11.0% | Growth Revenue=+4.1%
[Analyst] Revisions Ratio: -0.20 (2 Up / 3 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 0.5% (Discount Rate 8.1% - Earnings Yield 7.6%)
[Growth] Growth Spread = +3.6% (Analyst 4.1% - Implied 0.5%)